Cargando…

Evaluation of pain susceptibility by taking blood pressure in patients with infections: A prospective comparative study

Pain sensitization leading to polyalgia can be observed during infectious diseases. The blood pressure cuff-evoked pain threshold (BPCEPT) has been used in previous studies as a screening tool for fibromyalgia. We aimed to use the BPCEPT as a screening test for detecting pain sensitization in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eldin, Carole, Boudjema, Sophia, Meddeb, Line, Boyer, Laurent, Soriano, Christophe, Parola, Philippe, Lagier, Jean-Christophe, Stein, Andreas, Gouriet, Frédérique, Gautret, Philippe, Million, Matthieu, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4100
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341363/ https://www.ncbi.nlm.nih.gov/pubmed/34397794 http://dx.doi.org/10.1097/MD.0000000000026511

Ejemplares similares

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Olfactory and gustative disorders for the diagnosis of COVID-19
por: Boudjema, Sophia, et al.
Publicado: (2020)

Long-term persistence of symptoms of dyspnoea in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Long-Term Persistence of Olfactory and Gustatory Disorders in COVID-19 Patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

Different pattern of the second outbreak of COVID-19 in Marseille, France
por: Gautret, Philippe, et al.
Publicado: (2021)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
por: Lagier, Jean Christophe, et al.
Publicado: (2020)

Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France
por: Eldin, Carole, et al.
Publicado: (2020)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj
por: Gautret, Philippe, et al.
Publicado: (2014)

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults
por: Colson, Philippe, et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Radiological diagnostic accuracy study comparing Lenke, Bridwell, BSF, and CT-HU fusion grading scales for minimally invasive lumbar interbody fusion spine surgery and its correlation to clinical outcome
por: Soriano Sánchez, José Antonio, et al.
Publicado: (2020)

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
por: Amrane, Sophie, et al.
Publicado: (2020)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
por: Colson, Philippe, et al.
Publicado: (2021)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Identification of dengue type 2 virus in febrile travellers returning from Burkina Faso to France, related to an ongoing outbreak, October to November 2016
por: Eldin, Carole, et al.
Publicado: (2016)

Thromboses in tuberculosis are linked to antiphosphatidylethanolamine antibodies levels: A cross-sectional study
por: Bessis, Simon, et al.
Publicado: (2019)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2021)

Human Gut Microbiota: Repertoire and Variations
por: Lagier, Jean-Christophe, et al.
Publicado: (2012)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Introduction of the SARS-CoV-2 Beta variant from Comoros into the Marseille geographical area
por: Hoang, Van Thuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vg97o3m6cs6gcst6p9j6fdrre7